DoddsEM. Ocular toxoplasmosis: clinical presentations, diagnosis and therapy. Focal points: Clinical Modules for Ophthalmologists. San Francisco, CA: American Academy of Ophthalmology; 1999:1-14.
2.
JonesJLHollandGN. Annual burden of ocular toxoplasmosis in the United States. Am J Trop Med Hyg. 2010;82:464-465.
HollandGN. Ocular toxoplasmosis: a global reassessment. Part 1: epidemiology and course of disease. Am J Ophthalmol. 2003;136:973-988.
5.
BowieWRKingASWerkerDH. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet. 1997;350:173-177.
6.
GlasnerPDSilvieraCKruszon-MoranD. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992;114:136-144.
7.
RemingtonJS. Toxoplasmosis in the adult. Bull N Y Acad Med. 1974;50:211-227.
StanfordMRTanHKGilbertRE. Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey. Br J Ophthalmol. 2006;90:1464-1467.
10.
MontoyaJGRemingtonJS. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis. 1996;23:277-282.
11.
RondayMJHLuyendijkLBaarsmaGSBollemeijerJGVan der LelijARothovaA. Presumed acquired ocular toxoplasmosis. Arch Ophthalmol. 1995;113:1524-1529.
12.
HollandGN. Ocular toxoplasmosis: the influence of patient age. Mem Inst Oswaldo Cruz. 2009;104:351-357.
13.
HollandGNEngstromREGlasgowBJ. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1988;106:653-667.
14.
RondayMJOngkosuwitoJVRothovaAKijlstraA. Intraocular anti-Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis. Am J Ophthalmol. 1999;127:294-300.
15.
JonesJLDargelasVRobertsJPressCRemingtonJSMontoyaJG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009:49:878-884.
16.
SmithJL. Long-term consequences of food-borne toxoplasmosis: effects on the unborn, the immunocompromised, the elderly, and the immunocompetent. J Food Protection. 1997;60:1595-1611.
17.
HovakimyanACunninghamETJr. Ocular toxoplasmosis. Ophthalmol Clin North Am. 2002;15:327-332.
18.
HollandGHO’ConnorGRBelfortRJr. Toxoplasmosis. In: PeposeJSHollandGHWilhelmusKR, ed. Ocular Infection and Immunity. St Louis, MO: Mosby-Year Book; 1996:1183-1223.
19.
RondayMJStilmaJSBarbeRF. Aethiology of uveitis in Sierra Leone, West Africa. Br J Ophthalmol. 1996;80:956-961.
20.
GriggMEGanatraJBoothroydJCMargolisTP. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis. 2001;184:633-639.
21.
RothovaAMeenkenCBuitenhuisHJ. Therapy for ocular toxoplasmosis. Am J Ophthalmol. 1993;115:517-523.
22.
SoheilianMSadoughiMMGhajarniaM. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology. 2005;112:1876-1882.